RECRUITING

Remote Smoking Cessation in Hospitalized Cardiac Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease

Official Title

Remote Smoking Cessation in Hospitalized Cardiac Patients: Bridging the Post-discharge

Quick Facts

Study Start:2022-08-12
Study Completion:2025-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05738408

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
  2. 2. live within 30 miles of UVMMC and are \>18 years of age
  3. 3. Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \>5 cigarette/day on average over the past 3 months)
  1. 1. severe dementia/Alzheimer's disease
  2. 2. an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
  3. 3. exercise limiting vascular or neuromuscular disease
  4. 4. Non-English Speaking
  5. 5. No reliable smart-phone
  6. 6. Current, regular use of smokeless tobacco or other form of non-combusted tobacco

Contacts and Locations

Study Contact

Sherrie Khadanga, MD
CONTACT
802-847-2700
sherrie.khadanga@uvmhealth.org
Diann Gaalema, PhD
CONTACT
diann.gaalema@med.uvm.edu

Study Locations (Sites)

University of Vermont Medical Center
Burlington, Vermont, 05405
United States

Collaborators and Investigators

Sponsor: University of Vermont Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-12
Study Completion Date2025-05

Study Record Updates

Study Start Date2022-08-12
Study Completion Date2025-05

Terms related to this study

Keywords Provided by Researchers

  • smoking cessation
  • secondary prevention

Additional Relevant MeSH Terms

  • Smoking Cessation